What is Lumedica Vision?
Lumedica Vision is at the forefront of developing innovative solutions for eye care professionals and researchers. Their flagship product, the OQ EyeScope 2.0, integrates advanced OCT hardware with sophisticated AI software to enhance diagnostic capabilities. By providing tools that improve the accuracy and efficiency of eye examinations, Lumedica Vision aims to significantly improve patient outcomes. The company's commitment to technological advancement positions it as a key player in the medical technology landscape, particularly within ophthalmology.
How much funding has Lumedica Vision raised?
Lumedica Vision has raised a total of $296K across 2 funding rounds:
Debt
$146K
Debt
$150K
Debt (2021): $146K with participation from PPP
Debt (2025): $150K led by Centrust Bank
Key Investors in Lumedica Vision
Centrust Bank
Centrust Bank is a financial institution that has provided debt financing to Lumedica Vision, indicating a role in supporting the company's capital structure and growth initiatives.
PPP
Public-Private Partnership
What's next for Lumedica Vision?
With the recent influx of capital, Lumedica Vision is poised for accelerated expansion and product development. The 'large-scale late-stage funding' context suggests the company is moving towards broader market penetration and potentially scaling its operations to meet increasing demand. This strategic investment will likely fuel further research into AI-driven diagnostics, enhance the capabilities of their OCT technology, and support the expansion of their commercial reach. Lumedica Vision's focus on improving patient care through cutting-edge technology indicates a strong trajectory for future innovation and market leadership.
See full Lumedica Vision company page
